Delivery Order SPE2DR25D3306-SPE2DR26F5F7J
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.30 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG transdermal patches (8-count package) on January 15, 2026, with completion scheduled for January 16, 2026. This is a firm fixed-price, non-set-aside contract with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,253.93 to AmerisourceBergen Drug Corp for Combipatch 0.05-0.25 mg transdermal patches (8-unit supply) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,791.52 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 31, 2025, and performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,557.17 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 mg transdermal patches (8-count packaging). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count packages) with a ceiling value of $1,048.84. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by November 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,284.92 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 mg transdermal patches (8-count package) on September 24, 2025, with completion targeted for September 25, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on December 9, 2025, for COMBIPATCH 0.05-0.14 mg transdermal patches (8 count) valued at $1,463.45. This non-competitive, firm fixed price delivery order is set to be completed by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8 count) with a ceiling value of $1,148.10. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 1, 2025. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $3,430.71 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count units). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. Performance is scheduled for completion by September 3,...
- The Defense Logistics Agency awarded a $2,151.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 MG transdermal patches (8-count packaging) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DR25D3306Indefinite Delivery Contract
- SPE2DR25D3306-SPE2DR26F5F7JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for a supply of Combipatch 0.05-0.14 mg transdermal patches (8-count package) with a ceiling value of $1,018.94. The contract employs firm fixed-price pricing and is not set aside for any specific business category, indicating it was competitively awarded. Performance will be executed from the company's Conshohocken, Pennsylvania location, with an ultimate completion date of January 15, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at up to $999.99 million through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs and other federal medical institutions. The company's contract portfolio with Defense Logistics Agency demonstrates its role as a critical vendor for federal medical procurement, particularly serving military treatment facilities and veteran healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/13/26 |